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C677T mutation of methylenetetrahydrofolate
reductase gene determined in blood or plasma 
multiple-injection capillary electrophoresis and
induced fluorescence detection
A r v e  U lv ik ,1* H e lg a  Refsum ,1 Leo A.J. K lu ijtm a n s ,2 and Per M agn e U e la n d i
We constructed an assay to detect the common C677T acquired and genetic factors [2], Frosst et al. [3], We 
mutation in the methylenetetrahydrofolate reductase recently demonstrated that a common mutation (allele 
gene. The mutation creates a JFfmfl recognition site frequency ~35%) in the methylenetetrahydrofolate reduc-
detected by restriction cleavage of a 198-bp fragment 
amplified in the polymerase chain reaction (PCR). Di-
tase (MTHFR) gene, characterized by a C to T substitution 
at nucleotide 677, creates a thermolabile enzyme variant.3
gested samples were subjected to capillary electrophore- In its homozygous form, this mutation predisposes to
sis with laser-induced fluorescence detection (CE-LIF), hyperhomocysteinemia, especially in folate-deficient sub-
with hydroxypropylmethylcellulose as the sieving ma- jects [3-5], Thermolabile MTHFR has itself been associ-
trix and SYBR Green I as the fluorescent dye. After ated with increased incidence of early
amplification but before digestion, we added to the PCR disease [6, 7],
mixture a fragment with the Hinfl  recognition site and a Determination of the MTHFR genotype will probably
15-bp truncation at the 3' end. Using this procedure, we become valuable for assessment of cardiovascular risk in 
could (a) verify completeness of digestion and monitor 
injection, (b) assign genotypes on the basis of pattern 
recognition, and (c) develop a multiple-injection mode 
with simultaneous separation of as many as eight sam­
ples. A seminested PCR protocol in combination with type in large populations or in r 
CE-LIF allowed genotyping of plasma/serum samples 20 mands high assay thr 
years old. blood cells in p lasm a/ser
; in rei
o r
i n d e x i n g  t e r m s : restriction enzyme a n a l y s i s
systems.
The C677T mutation in MTHFR creates a Hin ft res tri c-
homocysteine • hyperhomocysteinemia • risk factors • don site that is detected by digestion of a polymerase
prem ature atherosclerosis • cardiovascular disease • her- chain reaction 
itable disorders • folate deficiency conventional
'R)~am fragment analyzed by 
electrophoresis /3/. Electro­
phoretic separation of DNA fragments by dynamic siev- 
Increased total homocysteine in the blood, "hyperhomo- ing in coated capillaries filled with entangled polymers 
cysteinemia," is an established risk factor for premature (e.g., linear polyacrylamide or cellulose derivatives) has 
atherosclerotic disease in the coronary, cerebral, and pe- recently become an attractive alternative, characterized by 
ripheral arteries 111. Hyperhomocysteinemia is caused by
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unsurpassed separation efficiency [81. High sensitivity of
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s iev in g  m ed iu m , co m b in ed  w ith  la ser-in d u ced  fluores- CE in s t r u m e n t a t io n
cence (LIF) detection [8]. We have recently demonstrated CE was performed on a Prince CE system from Prince
the applicability of the novel monomeric dyes, SYBR 
Green I, YO-PRO-1, and Thiazole Orange, for the analysis 
of DNA fragments by capillary electrophoresis (CE) and 
LIF detection (CE-LIF) [9].
Here, we demonstrate a method for analyzing the 
C677T mutation in the MTHFR gene, in which the tech­
nique based on PCR amplification and Hind restriction 
cleavage [3] has been modified and adapted to a CE-LIF 
format. The modifications include addition of a truncated 
fragment, which serves as a digestion control and time 
marker, and use of a nested PCR protocol, required when 
plasma or serum samples are the sources of DNA. Be­
cause commercial CE systems visually are equipped with 
a single capillary, we devised a multiple-injection mode 
that allows simultaneous separation of as many as eight 
samples, thereby increasing the sample throughput of the 
assay.
Materials and Methods
Technologies (Emmen, The Netherlands), equipped with 
an in-house-built LIF detector. Laser excitation was at 488 
nrn (produced with a 20-mW argon laser from Uniphase, 
Herts, UK), and the light was focused 30 /xm below the 
end of the capillary that was placed in a rectangular 
sheath-flow cuvette. A sheath flow of electrophoresis 
buffer (without entangled polymer) was delivered at a 
rate of 30 /xL / h. The emitted light was collected through 
a 535-nm band-pass filter (no. 535DF35; Omega Optical, 
Brattleboro, VT).
We used a 50 jtxm (i.d.)/192 ¡xm (o.d.) silica capillary 
(Polymicro Technologies, Phoenix, AZ) coated according 
to Hjerten [11]. Total capillary length, and the distance 
between the column inlet and detector window, was 42 cm.
Caesar software (Version 4.1) from Prince Technologies 
was used for data collection and processing. Electrophero- 
grams used to prepare the illustrations were transferred 
as text files to an Apple Macintosh computer and redrawn 
by Sigma Plot (Version 5.0; Jandel Scientific, Erkrath, 
Germany).
REAGENTS DNA EXTRACTION
Three different methods for DNA extraction were used, 
involving magnetic particles, filtration, or adsorption to 
silica. '
The DNA Direct kit was obtained from Dynal (Oslo,
Norway) and the QIAamp Blood Kit from Qiagen 
(Hilden, Germany). Reagents and reaction tubes (Thin 
Walled GeneAmp) for PCR were purchased from Perkin-
Elmer (Norwalk, CT), except that the Taq polymerase Magnetic particle method. DNA was extracted from whole 
(Supertaq) was obtained from HT Biotechnology (Cam- blood by using the DNA Direct kit and following the 
bridge, UK). The four primers referred to as forward (F), instructions provided by the manufacturer. Briefly, 5 ju-L 
outer forward (OF), reverse (R), and control reverse (CR) of whole-blood sample was mixed with 200 /xL of mag- 
were synthesized by Eurogentec (Seraing, Belgium). The F ne tic particles suspended in a buffer; this lysed the blood 
and R primers have been previously published /3J. The SF cells and allowed the DNA to adhere to the magnetic 
and CR primers were designed with the aid of the particles. The particles were washed twice and thereafter
computer program Oligo (National Biosciences, Ply­
mouth, MN). Their sequences were 5'-GGAGCTTTGAG-
GCTGACC-TGAA-3' (F), 5'-TGAAGGAGAAGGTGTCT- 
GCGGGA-3' (OF), 5'- AGG ACGGTGCGG-TG AG AGTG- 
3' (R), and 5 '-GAGTGGGGTGGAGGGAGCTTAT-3' (CR).
SYBR Green I (concentration not given), dissolved in
sulfoxide, was purchased from 
Probes (Eugene, OR), and working stock solution was 
prepared daily and stored in the dark at room tempera­
ture. Acrodisc polyvinylidene difluoride filters (0.45-/xm 
pore size) were from Gelman Sciences (Ann Arbor, MI).
The microtiter plate filtration unit MADV N65 was 
from Millipore (Bedford, MA). Hydroxypropylmethylcel- 
lulose (4000 cP at 25 °C, 20 g /L  aqueous solution) and 
other chemicals (analytical- or molecular biology-grade) 
were obtained from E. Merck (Darmstadt, Germany) and 
Sigma Chemical Co. (St. Louis, MO). Solutions containing
resuspended in 40 /xL of Tris-EDTA buffer (10 mmol/L 
Tris-HCl, 1 m m ol/L  EDTA, pH 8.0); 5 ¡xL of the particle 
suspension was used for PCR.
Filtration. Serum or plasma samples (100 /xL) were loaded 
on a microtiter plate filtration unit (MADV N65), and cell 
debris was trapped on the filters by centrifugation at 500# 
for 5 min. DNA was released from the filters by adding 40 
fjtL of ion-exchange purified water and heating at 95 °C 
for 2 min. We used 15 /xL of the crude DNA preparation 
for the first PCR reaction in the seminested protocol.
Adsorption to silica. Serum or plasma samples were puri­
fied with the QIAamp Blood Kit, according to the instruc­
tions of the manufacturer. Briefly, 200 /xL of plasma was 
treated with a lysis buffer containing proteinase K. Iso- 
propanol was added to the solution, and the mixture was 
applied to a column containing an integrated silica mem-
hydroxypropylmethylcellulose were prepared as de- brane and centrifuged. The DNA adhered to the mem- 
scribed elsewhere [101. Water, doubly distilled and puri- brane, and impurities were removed by a washing step, 
fied with a MilliQ Plus Water Purification System (Milli- Captured DNA was eluted in 50 /xL of 10 m mol/L Tris
pore), was used to prepare all aqueous solutions. buffer, pH 9.0, and 15 /xL of the effluent was used for PCR.
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PCR
The PCR reaction mixture contained 10 m m ol/L  Tris-HCl
template DNAf  y  X L X  L t v x x  L U /J IV L  I . V ^  ^  ^  -- -----------  j  ^  ?
the C677T mutation, w ere  u sed  to produce the control 
(pH 9.0), 50 m m ol/L  KC1, 1.5 m m ol/L  MgCl2/ 0.1 g /L  fragment that was ad d ed  to  the PCR products before 
gelatin, 1 m L/L Triton X-100, 125 /xmol/ L of each dNTP, Hinfl digestion. One function  of the control fragment was 
0.2 jumol/L of each primer, 0.2 U of Taq polymerase, and to verify complete d igestion  by the restriction enzyme 
template DNA in a total volume of 100 ¡xL. A Perkin- (see below). Fig. 1 outlines the positions of the primers-
Elmer 480 thermocycler was vised for a two-step thermo- ' ' ” ' ' J : i i ......m utation a n d  the sizes of the different
cycling profile: dénaturation at 94 °C for 15 s and anneal- products before and after treatm ent with restriction en
ing at 55 °C for 30 s, the temperature cycles being 
preceded by 2 min at 94 °C and concluded with 5 min at 
72 °C.
zyme
S IN G L E -IN J E C T IO N  A N A L Y S IS
A seminested protocol and a single-step protocol were DNA samples were PCR-amplified, digested w ith
constr The seminested protocol included the OF after addition of the control fragment
and R primers in the first reaction of 25 cycles; 1 ¡xL of the to CE-LIF. A sample from a heterozygous subject show ed 
first reaction was then transferred to the second reaction, four major peaks: the p rim ers , the digested control frag
which consisted of 40 cycles w ith the F and R primers. The fragment m utated allele (T), and
single-step protocol was identical to the second reaction fragment of the normal a lle le  (C) (Fig. 2).
of purified DNA.
template The control fragment (f) provided a reference foi 
migration of C and T, and  the  combinations of f-T, f-
RESTRICTION ENZYME CLEAVAGE
The C677T substitution creates a Hinfl recognition se­
quence. A solution containing Hinfl, reaction buffer, and a 
183-bp control fragment was pipetted in 15-¡xL aliquots, 
and 10 fxL of PCR product was added. The final mixture 
contained 2 U of Hmfl in I X  Gibco buffer II (50 m m ol/L  
Tris-HCl, pH  8.0, 10 m m ol/L  MgCl2, and 50 m m ol/L  
NaCl) and a 2:5 dilution of the PCR reaction buffer (see 
preceding section) in a total volume of 25 /xL. Incubation 
was at 37 °C for 90 min.
CAPILLARY ELECTROPHORESIS
Electrophoresis buffer was 89 m m ol/L  Tris-borate, pH 
8.3, containing 1 m m ol/L  EDTA. Separation buffer was 
electrophoresis buffer containing 6 g /L  hydroxypropyl- 
methylcellulose as sieving matrix. The separation buffer 
was passed through the Acrodisc filters before use. SYBR 
Green I (1:20 000 final dilution of 
added to the separation buffer after filtration (to avoid 
adsorption of dye to the filter matrix).
was
each series of ca ary was
flushed with the electrophoresis buffer for 30 s and 
filled with separation buffer by applying a pressure of 200 
kPa for 150 s. Samples were diluted 1:50 in distilled water
¿paration
was between 500 and 700 V / cm, and temperature was set 
at 20 °C.
Results and Discussion
PRIMERS A N D  PCR PRODUCTS
amplifi catio
(denoted here as F and R) were the same as previously 
described [3]. A third primer, OF, was constructed, posi­
tioned 26-bp 5' to the F primer, and used in concert with 
the R primer to produce the first fragment in the semin­
ested protocol. A fourth primer, CR, was constructed and 
positioned 1,5-bp 5' to the R primer. Primers CR and F,
OF F exon intron CR R
control fragment 
analysis fragment
I
t
I
»
*II
183 bp 
198 bp
Digestion with Hinfl
control fragment 
mutated allele 
normal allele
160 bp 
175 bp 
198 bp
Fig. 1. Positions of primers— OF  (outer forward), F (forward), R (re­
verse), and CR (control reverse)— relative to the mutation site (arrow) 
and an exon/intron boundary.
The relative sizes of the PCR products are shown before and after restriction 
enzyme cleavage. All lengths are drawn to scale.
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Fig. 2. Electropherogram of a single heterozygous (CT) sample, illu 
trating peaks forthe primer (p), control fragment (/}, mutated allele (7)
and normal allele (C).
For M/a (the analysis window), W (a  window spanning and the primers), and t 
(the time at which the control fragm ent elutes at the detector), the actual value; 
were 0.18, 0.80, and 3.77 min, respectively. Injection was ! 1S kV for
and separation field strength was 6 6 0  V/cm (constant voltage). Othar conditions 
were as described in Materials and  Methods.
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f-T-C peaks formed characteristic patterns for each of the by Wa, t f/ As, and g as shown by the expression :
three possible genotypes (TT, CC, and CT, respectively). 
The digestion control was built into the pattern recogni-
[ff + Wa (g l)As] /g  <  AL <  ( if -  gAs) /  (g 1) (1)
tion design, in that an incomplete cleavage was revealed From requirement (b) it also follows that A,_ had  to be
fragment larger than one group, that is AL >  As + W n- To avoid
position between the mutated (T) and the normal (C) coelution between PCR fragments and p r im e rs  (require-
fragment. Remnants ment a), a stronger restriction was AL >  W. B y  substitut-
indicated with arrows in Fig. 3. A further function of the ing W for AL in expression 1, we obtained t h e  following 
control fragment was to differentiate between a failed expression for gmax: gmax <  (tf + W )/(A a + W ) .
PCR amplification (only control fragment was detected Using the values of ff, W, and Wa from. Fig. 2, we
after amplification) and inadequate sample injection (no determined a gmax of 4 (i.e., 4 X 2  sam ples 
fragments were detected).
MULTIPLE-INJECTION ANALYSIS
simultaneously). Fig. 4 depicts schematically t h e  distribu­
tion of eight injections (g = 4) in the cap illa ry  at the 
boundary conditions for AL (A and B). E xpression  1 and
When adapting the single-injection analysis to a multiple- the expression for gmax can be derived from t h i s  Fig. 4. 
injection mode, the essential requirements were (a) to Reduction of g from its maximal value in c reases  the
V p n r
avoid coelution of primers from one sample with the separation between the peaks of successive injections,
digested PCR fragments from another sample, and (b) to thereby allowing for some variability in s y s te m  perfor-
avoid injection during the time interval when the PCR mance that affects parameters Wa, W, and tf. Thus, we
fragments pass the detector. The analytical parameters routinely used g =  3 for calculating the a p p ro p ria te  AL.
used for designing an optimized injection protocol that Fig. 3 shows the last six injections in  a r u n  with 10
would meet these requirements are defined in Fig. 2: the injections (g = 3). Mean analysis time was 1 .5  min per
analysis window Wa; the time interval W, which spans Wa 
and the primers; and t ir the time at which the control 
fragment elutes at the detector.
sample.
The above discussion is based on  g roup ing  tw o  injec­
tions together, separated by a single As. C onceivably , each 
The injections were performed with alternating time group could comprise more than tw o in jections. The 
intervals As (small interval) and AL (long interval). Two grouping of the injections depends on the  analytical 
injections separated by As defined a group. As had to be parameters (e.g., Wa, W, and £f), the relative values of 
>W a to avoid overlap between analysis windows, and which can be modified by changing the p o s i t io n  of the 
maximal separation was obtained when As = W / 2. Thus, PCR primers that determine the sizes of t h e  analysis 
an optimal As (balancing analysis throughput and sepa- products and control fragment(s). In practice, t h e
ration) would be within the interval Wa <  A W / 2 . ence between the cut and uncut fragments s h o u ld  be as
To fulfill the second requirement above (b), g groups small as possible. This would decrease W a a n d  m ake  the
were distributed in the capillary (by means of varying AL) small part of the cut fragment elute close to t h e  primers,
so that elution of a group at the detector was followed by which would allow several injections to b e  grouped
injection of a group at the capillary inlet, and vice versa. within the time period W. The param eters also reflect the
This put some limitations on AL, which were determined resolution properties of the system, which i n  tu rn  are
0.4 F
0.3 -
^  02 l l
CC
0.1 -
0.0 -
Migration time (min)
Fig. 3. Electropherogram of a multiple-injection run, showing the last six samples of a run with 1 0  injections.
Shaded boxes emphasize the size and distribution of the analysis windows. The genotypes are two homozygous normal (CC), two heterozygous (CT), one homozygous
normal (CC), and a homozygous mutated (77), in that order. Remnants of the undigested control fragment are indicated with arrows, p, f, and electrophoretic conditions 
as in Fig« 2.
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Fig. 4. Schematic presentation of multiple-injec­
tion assay, wherein the distribution of injections 
(g = 4) Is represented by the migration of the 
respective control fragments fx through f8 (fg will 
be the next injection).
Because the control fragments move with constant 
velocity, their separation in time is proportional to their 
separation in distance, and can be drawn on the same 
axis. The time intervals A( and As are indicated, and the 
variables Wa and W (for Injections f3 and respec­
tively) are drawn at the size they would have at elution. 
Panels A and B show the distribution at AL((1UI)0 and 
AUmln)l respectively.
related to type and  concentration of the s iev in g  matrix several samples with high DNA content. Based on previ-
and fluorescent dye, temperature, and field s treng th  [8],
DURABILITY OF THE SEPARATION M ATRIX
a m m e d
ous observations [9], this can probably be explained by 
extraction of dye by the DNA. The electrophoretic perfor­
mance was stabilized by increasing the SYBR Green I 
concentration to dilution 1:20 000 in the present protocol.
many
be perform ed w ith o u t  rep lacing th e  s e p a r a t io n  m atrix. d n a  p u r if ic a t io n , a m p l if ic a t io n , a n d  v a l id a t io n
during the course
number OF CE-LIF ASSAY
m u ltip le The CE-LIF assay described here was developed to ana-
eluted closer to the PCR fragments).
W was observed (i.e., th e  primers lyze the MTHFR C677T mutation in the clinical setting but
With
m ed iu m , 
ition tim e
also to genotype large populations as part of prospective 
I (dilution studies based on stored samples. In the routine labora- 
a  decrease tory, DNA is obtained from whole blood, whereas stored 
paration of sample collections often contain only serum or plasma.
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Fig. 5. Evaluation of single vs nested PCR and of CE-LIF vs agarose gel electrophoresis for genotyping 30 plasma samples for MTHFR gene.
All samples were purified by the Qiagen method, PCR-ampllfied, and digested by Hind: (A) single-step PCR and CE-LIF analysis, (S) seminested PCR and CE-LIF analysis, 
(C) seminested PCR In combination with conventional agarose gel electrophoresis and ethidium bromide staining. Samples In C are the same as In 6, except that the 
control fragment was not added. The column heights indicate the  relative amounts of PCR products, obtained by dividing the area of the allele peak(s) by the area of 
the control fragment peak.
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We used the DNA Direct Kit for extraction of DNA C om m i
from whole blood. This method is based on capture of the onstration Project (contract no. BMH4
DNA in lysed blood onto magnetic beads. The extraction Norwegian
is carried out manually, but we are currently automating and the Norwegian Research C o u n c il . W e th an k  Norman 
it, using the BioMek 2000 robot from Beckman Instru- J. Dovichi (University of Alberta, C anada) for provid ing a 
ments (Fullerton, CA). Using this technique in combina- sheath-flow cell for our in-house-built LIF detector, 
tion with single-step PCR, we could determine the geno­
type of -100% of the whole-blood samples. For plasma/ 
serum samples, however, this DNA extraction procedure 
was inadequate. Moreover, combining this extraction 
approach with the seminested PCR technique described 
in Materials and Methods correctly identified the genotype 
of <10% of the serum/plasma samples.
Methods for the extraction of DNA from serum ['12,13] 
and plasma [13] have been reported before. In the present 
work, we established and demonstrated the applicability 
of two alternative methods. Collecting cell debris by 
filtration in a multiwell unit in combination with the 
seminested PCR protocol was successful with serum 
samples (29 of 30 were genotyped) but not with plasmas 
(5 of 30 were genotyped).
The silica adsorption method (QIAamp) was used to 
extract DNA remaining in 30 plasma samples that had 
been stored at —20 °C for 20 years. Fig. 5 shows the 
genotypes and the relative amounts of PCR products.
Signals from 15 of the 30 samples could be detected by 
CE-LIF after the single-step PCR protocol (Fig. 5A), 
whereas 29 of 30 were positive after PCR amplification 
with the seminested protocol (Fig. 5B). We also compared 
the sensitivity of CE-LIF (Fig. 5B) and a conventional 
agarose gel stained with ethidium bromide (Fig. 5C) for 
determining the genotypes of the samples amplified by 
seminested PCR. Some (5-7) of the samples genotyped by 
CE-LIF could not be determined by conventional agarose 
gel electrophoresis.
The versatility of the CE-LIF method is demonstrated 
by reliable genotyping based on highly variable amounts 
of PCR products. In the experiments depicted in Fig. 5, the 
ratio of the largest to the smallest amount was 117.
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